Literature DB >> 26913370

The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.

Delphine De Smedt1, Dirk De Bacquer2, Johan De Sutter3, Jean Dallongeville4, Sofie Gevaert5, Guy De Backer2, Jan Bruthans6, Kornelia Kotseva7, Željko Reiner8, Lale Tokgözoğlu9, Els Clays2.   

Abstract

OBJECTIVE: The aim of this study was to investigate gender related differences in the management and risk factor control of patients with coronary heart disease (CHD), taking into account their age and educational level.
METHODS: Analyses are based on the EUROASPIRE IV (EUROpean Action on Secondary and Primary Prevention through Intervention to Reduce Events) survey. Males and females between 18 and 80years of age, hospitalized for a first or recurrent coronary event were included in the study.
RESULTS: Data were available for 7998 patients of which 75.6% were males. Overall, females had a worse risk factor profile compared to males and were more likely to have 3 or more risk factors (29.5% vs. 34.9%; p<0.001) across all age groups. A significant gender by education interaction (p<0.05) and gender by age interaction effect (p<0.05) was found. Furthermore, males were more likely to have a LDL-cholesterol on target (OR=1.50[1.28-1.76]), a HbA1c on target (OR=1.33[1.07-1.64]), to be non-obese (OR=1.45[1.30-1.62]) and perform adequate physical activity (OR=1.71[1.46-2.00]). In contrast males were less likely to be non-smokers (OR=0.71[0.60-0.83]). Furthermore, males were less likely to have made a dietary change (OR=0.78[0.64-0.95]) or a smoking cessation attempt (OR=0.70[0.50-0.96]) and more likely to have received smoking cessation advice if they were smokers (OR=1.52[1.10-2.09]).
CONCLUSION: Whereas gender differences in CHD treatment are limited, substantial differences were found regarding target achievement. The largest gender difference was seen in less educated and elderly patients. The gender gap declined with decreasing age and higher education.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Coronary heart disease; EUROASPIRE; Gender

Mesh:

Year:  2016        PMID: 26913370     DOI: 10.1016/j.ijcard.2016.02.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  27 in total

1.  Gender differences in cardiovascular risk factors in patients with coronary artery disease and those with type 2 diabetes.

Authors:  Ichiro Wakabayashi
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 2.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

3.  Sex differences in risk factor management of coronary heart disease across three regions.

Authors:  Min Zhao; Ilonca Vaartjes; Ian Graham; Diederick Grobbee; Wilko Spiering; Kerstin Klipstein-Grobusch; Mark Woodward; Sanne Ae Peters
Journal:  Heart       Date:  2017-09-20       Impact factor: 5.994

4.  Dietary inflammatory index: a potent association with cardiovascular risk factors among patients candidate for coronary artery bypass grafting (CABG) surgery.

Authors:  Mahdieh Abbasalizad Farhangi; Mahdi Najafi
Journal:  Nutr J       Date:  2018-02-13       Impact factor: 3.271

5.  Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis.

Authors:  Min Zhao; Mark Woodward; Ilonca Vaartjes; Elizabeth R C Millett; Kerstin Klipstein-Grobusch; Karice Hyun; Cheryl Carcel; Sanne A E Peters
Journal:  J Am Heart Assoc       Date:  2020-05-20       Impact factor: 5.501

Review 6.  Arterial Hypertension: Individual Therapeutic Approaches-From DNA Sequencing to Gender Differentiation and New Therapeutic Targets.

Authors:  Constantin-Tudor Luca; Simina Crisan; Dragos Cozma; Alina Negru; Mihai-Andrei Lazar; Cristina Vacarescu; Mihai Trofenciuc; Ciprian Rachieru; Laura Maria Craciun; Dan Gaita; Lucian Petrescu; Alexandru Mischie; Stela Iurciuc
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

7.  Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study.

Authors:  Xiaomei Zhang; Linong Ji; Xingwu Ran; Benli Su; Qiuhe Ji; Dayi Hu
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

8.  Patient confidence regarding secondary lifestyle modification and knowledge of 'heart attack' symptoms following percutaneous revascularisation in Japan: a cross-sectional study.

Authors:  Hiroki Kitakata; Takashi Kohno; Shun Kohsaka; Junko Fujino; Naomi Nakano; Ryoma Fukuoka; Shinsuke Yuasa; Yuichiro Maekawa; Keiichi Fukuda
Journal:  BMJ Open       Date:  2018-03-16       Impact factor: 2.692

9.  Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.

Authors:  Teppo Repo; Markku Tykkyläinen; Juha Mustonen; Tuomas T Rissanen; Matti Ketonen; Maija Toivakka; Tiina Laatikainen
Journal:  Int J Environ Res Public Health       Date:  2018-04-11       Impact factor: 3.390

Review 10.  Platelet Responses in Cardiovascular Disease: Sex-Related Differences in Nutritional and Pharmacological Interventions.

Authors:  Valeria Gasperi; M Valeria Catani; Isabella Savini
Journal:  Cardiovasc Ther       Date:  2020-05-19       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.